Biotech / Medical: Sequenom, Inc. (SQNM)
Posts: 308 | Member SubjectMarks: 59 | No Bans

Add SubjectMark | Show Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: Nav Toor -- (Not Moderated) -- Started: 1/24/2000 1:29:00 PM  Revision History

Previous 10 | Next 10 | View Recent | Post Message Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsDate
308Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and ConferSavant-04/25/2013 02:28 PM
307Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year OfSavant-03/09/2013 03:27 AM
306 Sequenom CMM's MaterniT21 PLUS LDT Now Reporting On Gender-Specific ChromosSavant-02/04/2013 11:30 AM
305Sequenom Announces Preliminary 2012 Operational Highlights SAN DIEGO, Jan. 6, Savant-01/31/2013 12:26 AM
304Sequenom Announces Participation At 31st Annual JP Morgan Healthcare Conference Savant-01/03/2013 02:10 AM
303 Dec 17th Sequenom provided update, late Friday night, on status of patent for mSavant-01/03/2013 02:09 AM
302I don't give the ACTC program much chance of succeeding.  DewDiligence_on_SI-11/13/2012 03:54 PM
301You mean...yet. ACTC, for one, is working on a stem cell treatment for wet anSavant-11/13/2012 03:22 PM
300I question the commercial value of this diagnostic: investorshub.advfn.com DewDiligence_on_SI-11/13/2012 01:19 PM
299Study Shows Sequenom CMM's RetnaGene LDT Accurately Predicts Risk of ProgresSavant-11/13/2012 11:02 AM
298Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2012 And AnnoSavant-11/13/2012 11:01 AM
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2013 Knight Sac Media. All rights reserved.